Closed System Transfer Devices Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Closed System Transfer Devices Market Size From 2025 to 2034?
In recent times, the closed system transfer devices market has seen swift growth. The market, which is projected to expand from $1.04 billion in 2024 to $1.18 billion in 2025, boasts a compound annual growth rate (CAGR) of 13.7%. The historic growth can be credited to multiple factors such as the upswing in oncology drug approvals, the amplifying emphasis on occupational safety, the increased necessity to limit needlestick injuries and contact with toxic drugs, heightened awareness about the potential risks of cytotoxic drug exposure, and the growing population of chemotherapy patients.
Anticipated to experience accelerated expansion in the ensuing years, the market size for closed system transfer devices is projected to reach $1.96 billion by 2029, reflecting a compound annual growth rate (CAGR) of 13.4%. This projected growth during the forecast period can be linked to the rise in cancer rates, the growing necessity for observing regulations for the secure administration of harmful drugs, increased awareness surrounding the use of closed system transfer devices, and the upscaling use of CSTDS for the transport of hazardous drugs, along with the growing number of drug approvals for cancer. The forecast period also sees key trends such as the launch of new products, safety measures, creation of user-friendly devices and digital platforms, heightened research and developmental activities, technological advancements, and the preference for membrane-to-membrane systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Closed System Transfer Devices Market?
The surge in cancer incidences is anticipated to drive the expansion of the closed-system transfer devices market. Cancer, identified by the uncontrolled proliferation of abnormal cells which invade surrounding tissues and metastasize to other parts of the body through blood and lymph systems, is becoming increasingly common. This rise can be attributed to lifestyle factors, environmental exposures, and a higher rate of infections. Closed-system transfer devices play a crucial role in cancer therapy, as they safeguard healthcare workers and patients from the risks associated with handling and administering chemotherapy medications. Their application promotes a more secure healthcare environment and improved cancer patient treatment outcomes. For example, the World Health Organization, a Switzerland-based intergovernmental organization, highlighted in February 2024 that by 2050, it is expected that cancer cases will surpass 35 million, a hefty 77% upward surge from the estimated 20 million cases projected for 2022. This substantial increase underscores the escalating global burden of cancer. Furthermore, the National Center for Biotechnology Information, a US-based intergovernmental organization, stated in January 2023 that there were 1,958,310 new cancer cases in the United States and approximately 609,820 cancer deaths are projected to happen in 2023. Hence, the escalating crisis of cancer is fueling the growth of the closed system transfer devices market.
Which Key Market Segments Comprise the Closed System Transfer Devices Market and Drive Its Revenue Growth?
The closed system transfer devicesmarket covered in this report is segmented –
1) By Type: Needleless Systems, Membrane-To-Membrane Systems
2) By Technology: Diaphragm-Based, Compartmentalized, Filtration
3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems
4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users
Subsegments:
1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters
2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp
Which Areas Are Leading Regions in the Closed System Transfer Devices Market Expansion Across the Globe?
North America was the largest region in the closed system transfer device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Strategic Trends Steering theClosed System Transfer Devices Market Direction?
Leading corporations in the closed system transfer devices (CSTD) sector are prioritizing the advancement of innovative syringe units. This is aimed at boosting safety, enhancing the user experience, lowering contamination risk, and meeting rigorous healthcare industry regulations. A full-volume use syringe unit refers to a specially designed syringe for delivering or administering its entire medication or liquid contents without extra dilution or mixing. For instance, in October 2023, Equashield, an American medical device firm, introduced the EQUASHIELD Syringe Unit. This FDA-cleared unit for full-volume usage allows for safer and more effective management of hazardous drugs. Its cutting-edge design stops the escape of vapours and the contamination of the plunger, making it a cost-efficient solution for medication compounding and administration.
View the full report here:
How Is the Closed System Transfer Devices Market Conceptually Defined?
Closed system transfer devices (CSTDs) are specialized drug transfer devices designed to mechanically prevent environmental contaminants from entering the system and to stop hazardous drugs or vapor concentrations from escaping. These devices create a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare environments.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
